Article Title,Year,Volume,Issue,Page Range,Author
Serum cholesterol and risk of suicide - A clinical catamnestic study,1999,3,3,150-152,Linhartova
Conduct disorders of immature drug users,2000,4,2,112-115,Skodacek
Cholesterol mental illness and violence an overview,2000,4,2,83-90,Balon
Anabolic androgenic steroids and suicidal behavior,2000,4,3,189-190,Hajek
Depressive symptoms in schizophrenia I. Clinical picture and differential diagnosis,2007,11,2,89-94,Marsalek
Suicidal patient and therapeutic intervention,2008,12,1,43-50,Praško
Has the development of new pharmacological agents stopped? Part II - Antidepressants,2014,18,2,98-105,Švestka
Ketamine in the treatment of depressive disorder,2014,18,4,193-205,Šóš
Psychological autopsy: Development and implementation of suicide research methods,2015,19,4,190-196,Grznár
Possible proteins of suicide - A pilot study,2018,22,2,54-59,Bobrov
Psychoeducation for depression,2020,23,2,93-98,Motlová
Preventing the risk of suicidal behavior among transgender and non-binary PeoPle - an imPortant domain of mental health,2022,26,4,136-141,Pavlica